63 related articles for article (PubMed ID: 24119900)
1. [Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].
Wang L; Shen J; Meng LJ; Fan WF; Wang J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):418-22. PubMed ID: 24119900
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer.
Wang L; Xie L; Wang J; Shen J; Liu B
BMC Gastroenterol; 2013 Dec; 13():173. PubMed ID: 24359226
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
4. SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen.
Shen J; Wei J; Wang H; Yang Y; Yue G; Wang L; Yu L; Xie L; Sun X; Bian X; Zou Z; Qian X; Guan W; Liu B
PLoS One; 2013; 8(10):e75564. PubMed ID: 24124496
[TBL] [Abstract][Full Text] [Related]
5. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.
Bosch LJ; Luo Y; Lao VV; Snaebjornsson P; Trooskens G; Vlassenbroeck I; Mongera S; Tang W; Welcsh P; Herman JG; Koopman M; Nagtegaal ID; Punt CJ; van Criekinge W; Meijer GA; Monnat RJ; Carvalho B; Grady WM
Clin Cancer Res; 2016 Sep; 22(18):4612-22. PubMed ID: 27121793
[TBL] [Abstract][Full Text] [Related]
6. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
[TBL] [Abstract][Full Text] [Related]
7. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
[TBL] [Abstract][Full Text] [Related]
8. A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer.
Shen J; Wei J; Wang H; Yue G; Yu L; Yang Y; Xie L; Zou Z; Qian X; Ding Y; Guan W; Liu B
J Transl Med; 2013 Mar; 11():73. PubMed ID: 23517622
[TBL] [Abstract][Full Text] [Related]
9. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
[TBL] [Abstract][Full Text] [Related]
10. WRN counteracts the NHEJ pathway upon camptothecin exposure.
Otsuki M; Seki M; Kawabe Y; Inoue E; Dong YP; Abe T; Kato G; Yoshimura A; Tada S; Enomoto T
Biochem Biophys Res Commun; 2007 Apr; 355(2):477-82. PubMed ID: 17303082
[TBL] [Abstract][Full Text] [Related]
11. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase.
Futami K; Takagi M; Shimamoto A; Sugimoto M; Furuichi Y
Biol Pharm Bull; 2007 Oct; 30(10):1958-61. PubMed ID: 17917271
[TBL] [Abstract][Full Text] [Related]
12. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells.
Futami K; Ishikawa Y; Goto M; Furuichi Y; Sugimoto M
Cancer Sci; 2008 May; 99(5):843-8. PubMed ID: 18312465
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional response to distinct growth factors is impaired in Werner syndrome cells.
Lutomska A; Lebedev A; Scharffetter-Kochanek K; Iben S
Exp Gerontol; 2008 Sep; 43(9):820-6. PubMed ID: 18625297
[TBL] [Abstract][Full Text] [Related]
14. Werner interacting protein 1 promotes binding of Werner protein to template-primer DNA.
Kanamori M; Seki M; Yoshimura A; Tsurimoto T; Tada S; Enomoto T
Biol Pharm Bull; 2011; 34(8):1314-8. PubMed ID: 21804224
[TBL] [Abstract][Full Text] [Related]
15. The effect of resveratrol on the Werner syndrome RecQ helicase gene and telomerase activity.
Uchiumi F; Watanabe T; Hasegawa S; Hoshi T; Higami Y; Tanuma S
Curr Aging Sci; 2011 Feb; 4(1):1-7. PubMed ID: 21204775
[TBL] [Abstract][Full Text] [Related]
16. Nonenzymatic role for WRN in preserving nascent DNA strands after replication stress.
Su F; Mukherjee S; Yang Y; Mori E; Bhattacharya S; Kobayashi J; Yannone SM; Chen DJ; Asaithamby A
Cell Rep; 2014 Nov; 9(4):1387-401. PubMed ID: 25456133
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin.
Koshiyama M; Fujii H; Kinezaki M; Ohgi S; Konishi M; Hidetaka N; Hayashi M; Yoshida M
Anticancer Res; 2000; 20(3A):1353-8. PubMed ID: 10928043
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma.
Khayat AS; Lobo Gatti L; Moura Lima E; de Assumpção PP; Nascimento Motta FJ; Harada ML; Casartelli C; Marques Payão SL; Cardoso Smith MA; Burbano RR
Clin Exp Med; 2005 Dec; 5(4):161-8. PubMed ID: 16362795
[TBL] [Abstract][Full Text] [Related]
19. Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases.
Lebel M; Monnat RJ
Ageing Res Rev; 2018 Jan; 41():82-97. PubMed ID: 29146545
[TBL] [Abstract][Full Text] [Related]
20. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration.
Turaga RV; Massip L; Chavez A; Johnson FB; Lebel M
Aging Cell; 2007 Aug; 6(4):471-81. PubMed ID: 17521388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
